Cien por Cien Natural has introduced a pioneering omega-3 product that offers substantial benefits. This new offering, 'Krill Phospholipids PL+DHA,' represents a major advancement in omega-3 supplements due to its composition: a concentrated blend of docosahexaenoic acid (DHA) encapsulated in phospholipids.
These phospholipids are particularly noteworthy for their dual solubility—both water and fat-soluble—which facilitates superior emulsification and the formation of micelles. This process maximizes the surface area available for nutrient absorption.
To prove the effectiveness of this supplement, Aker BioMarine has conducted a clinical trial, the results of which have not yet been published, that demonstrates a tenfold improvement in the absorption of omega-3 fatty acids (both EPA and DHA) when formulated with PL+ phospholipids.
Dual-Solubility Omega Supplements
Cien Por Cien Natural Debuts a New Omega-3 Product
Trend Themes
-
Enhanced Bioavailability — Dual-solubility phospholipids significantly increase nutrient absorption and efficacy in dietary supplements.
-
Clinical Trials on Nutritional Supplements — Rigorous testing and validation through clinical trials are becoming a standard to establish effectiveness and gain consumer trust.
-
Concentrated Nutrient Formulations — High-concentration DHA encapsulated in innovative delivery systems is setting new standards in the omega-3 market.
Industry Implications
-
Nutritional Supplements — The introduction of dual-solubility components is revolutionizing the ease of nutrient absorption for consumers.
-
Pharmaceuticals — Phospholipid-based formulations present new opportunities for efficient drug delivery mechanisms.
-
Functional Foods — Innovations in nutrient delivery can enhance the health benefits and market appeal of fortified food products.